Kestra Medical Technologies (NASDAQ:KMTS) Coverage Initiated at Wolfe Research

Wolfe Research initiated coverage on shares of Kestra Medical Technologies (NASDAQ:KMTS) in a research report report published on Monday, Marketbeat.com reports. The firm issued an outperform rating and a $29.00 target price on the stock.

KMTS has been the subject of a number of other reports. Wells Fargo & Company initiated coverage on Kestra Medical Technologies in a research note on Monday. They set an “overweight” rating and a $28.00 price target for the company. Stifel Nicolaus initiated coverage on Kestra Medical Technologies in a research note on Monday. They set a “buy” rating and a $28.00 target price for the company. Piper Sandler started coverage on shares of Kestra Medical Technologies in a report on Monday. They issued an “overweight” rating and a $27.00 price target for the company. Finally, The Goldman Sachs Group started coverage on shares of Kestra Medical Technologies in a research note on Monday. They issued a “neutral” rating and a $24.00 price objective on the stock. One research analyst has rated the stock with a hold rating and five have assigned a buy rating to the stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $27.67.

Kestra Medical Technologies Price Performance

Shares of NASDAQ:KMTS opened at $25.70 on Monday. Kestra Medical Technologies has a twelve month low of $20.00 and a twelve month high of $26.06.

About Kestra Medical Technologies

We are a commercial-stage, wearable medical device and digital healthcare company focused on transforming patient outcomes in cardiovascular disease using monitoring and therapeutic intervention technologies that are intuitive, intelligent, and connected. We have developed and are commercializing our Cardiac Recovery System platform, a comprehensive and advanced system that integrates monitoring, therapeutic treatment, digital health, and patient support services into a single, unified solution.